Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Pembrolizumab promising for lung cancer, clinical outcomes correlate with biomarker

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.04.15
Views: 1892

Dr Edward Garon - David Geffen School of Medicine at the University of California, Los Angeles, USA

Dr Garon presents the results of a trial looking at the use of pembrolizumab in the treatment of advanced, non-small cell lung cancer, at a press conference at AACR 2015.

Read the news story for more or watch the interview for more.

Related videos

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation